ArticleNature communications2023

Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson's disease.

Satra Nim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.